Among these, the highest frequency of alterations in XRCC1 (>6%) was observed in patients with uterine carcinosarcoma (UCS), where “Amplification” was the predominant type of alteration (Figure 6B). This evidence concerns the gene XRCC1 and uterine carcinosarcoma.